Neuroprotective effects of hypothermia and erythropoietin after perinatal asphyxia in newborn rats

J Matern Fetal Neonatal Med. 2013 Oct;26(15):1506-9. doi: 10.3109/14767058.2013.789846. Epub 2013 May 2.

Abstract

Objective: Evaluation of neuroprotective effects of hypothermia, erythropoietin and their simultaneous use after perinatal asphyxia in newborn rats.

Method: Hysterectomy was performed to Wistar female rats on the last day of gestation. Perinatal asphyxia was induced by submersion of uterus containing pups in saline for 15 min. After resuscitation, pups were randomized into 4 groups, 15 animals in each: G1 - asphyxia; G2 - asphyxia + hypothermia (rectal temperature 33 °C for 1 h); G3 - asphyxia + erythropoietin (Darbepoetin-α 2.5 μg, intraperitoneally) and G4 - asphyxia + erythropoietin + hypothermia. Pups were sacrificed on 7th day of life and histopathological analysis of hippocampus was performed.

Results: Measure of damage to dorsal, ventral and entire hippocampus was significantly lower in groups G2, G3 and G4 than in group G1 (p ~ 0.00; respectively). Measure of damage to hippocampus in group G4 was significantly lower than in group G2 (p = 0.029).

Conclusions: This study demonstrates that simultaneous use of hypothermia and erythropoietin has more expressed neuroprotective effects than sole use of hypothermia after perinatal asphyxia in newborn rats.

MeSH terms

  • Animals
  • Animals, Newborn*
  • Asphyxia Neonatorum / therapy*
  • Brain Diseases / pathology
  • Brain Diseases / prevention & control*
  • Combined Modality Therapy
  • Disease Models, Animal
  • Erythropoietin / administration & dosage*
  • Female
  • Hippocampus / pathology
  • Hypothermia, Induced*
  • Neurons / pathology
  • Neuroprotective Agents*
  • Pregnancy
  • Rats
  • Rats, Wistar

Substances

  • Neuroprotective Agents
  • Erythropoietin